Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00796757
What this trial is testing

Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 146
Testing effectiveness (Phase 2)UnknownNCT04647695
What this trial is testing

IFN-beta 1b and Remdesivir for COVID19

Who this might be right for
Covid19
The University of Hong Kong 100
Post-approval studies (Phase 4)Ended earlyNCT01005095
What this trial is testing

The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients

Who this might be right for
MULTIPLE SCLEROSIS
Carmel Medical Center 45
Testing effectiveness (Phase 2)Study completedNCT00148837
What this trial is testing

Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Who this might be right for
Hepatitis C, ChronicFibrosis
French National Agency for Research on AIDS and Viral Hepatitis 112
Large-scale testing (Phase 3)Study completedNCT03222583
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 546
Testing effectiveness (Phase 2)Study completedNCT00241241
What this trial is testing

Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera

Who this might be right for
Polycythemia Vera
PV-Nord 40
Testing effectiveness (Phase 2)Study completedNCT01404936
What this trial is testing

Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT01016912
What this trial is testing

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 51
Large-scale testing (Phase 3)Study completedNCT00370071
What this trial is testing

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bayer 39
Large-scale testing (Phase 3)UnknownNCT02801383
What this trial is testing

Recombinant Human Interferon a-2b Gel for HPV-16 and/ or HPV-18 Gynecological Infections

Who this might be right for
Cervical HPV-16 and / or HPV-18 Infection
Lee's Pharmaceutical Limited 100
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Large-scale testing (Phase 3)Study completedNCT02732639
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 31
Testing effectiveness (Phase 2)Study completedNCT01100528
What this trial is testing

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more
Case Comprehensive Cancer Center 38
Post-approval studies (Phase 4)Study completedNCT00245414
What this trial is testing

Trial of Pegasys® in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Chugai Pharmaceutical 108
Testing effectiveness (Phase 2)Study completedNCT00001114
What this trial is testing

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Post-approval studies (Phase 4)Study completedNCT01264367
What this trial is testing

Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

Who this might be right for
HBeAg(+) Chronic Hepatitis B
Bukwang Pharmaceutical 60
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Large-scale testing (Phase 3)Study completedNCT01358864
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 678
Very early researchEnded earlyNCT00882193
What this trial is testing

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Who this might be right for
Chronic Hepatitis CGenotype 1Relapse
University of Nebraska 2
Testing effectiveness (Phase 2)Study completedNCT00656006
What this trial is testing

Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

Who this might be right for
Chronic Hepatitis C
Human Genome Sciences Inc. 43
Next Page